MX352708B - Use of n-acetylphenylalanylmethionine and chemical derivatives thereof as inhibitors of the neuraminidase of human and animal influenza virus. - Google Patents
Use of n-acetylphenylalanylmethionine and chemical derivatives thereof as inhibitors of the neuraminidase of human and animal influenza virus.Info
- Publication number
- MX352708B MX352708B MX2014001768A MX2014001768A MX352708B MX 352708 B MX352708 B MX 352708B MX 2014001768 A MX2014001768 A MX 2014001768A MX 2014001768 A MX2014001768 A MX 2014001768A MX 352708 B MX352708 B MX 352708B
- Authority
- MX
- Mexico
- Prior art keywords
- acetylphenylalanylmethionine
- neuraminidase
- inhibitors
- human
- influenza virus
- Prior art date
Links
- WKZUDETWSFSLBB-KBPBESRZSA-N (2s)-2-[[(2s)-2-acetamido-3-phenylpropanoyl]amino]-4-methylsulfanylbutanoic acid Chemical class CSCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(C)=O)CC1=CC=CC=C1 WKZUDETWSFSLBB-KBPBESRZSA-N 0.000 title abstract 3
- 102000005348 Neuraminidase Human genes 0.000 title abstract 2
- 108010006232 Neuraminidase Proteins 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title 1
- 239000000126 substance Chemical class 0.000 title 1
- 241000712461 unidentified influenza virus Species 0.000 title 1
- 230000002255 enzymatic effect Effects 0.000 abstract 1
- 206010022000 influenza Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Landscapes
- Pyrane Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention is related to the use of N-acetylphenylalanylmethionine for preparing a pharmaceutical composition useful in the treatment of viral influenza. The N- acetylphenylalanylmethionine has the property of inhibiting the enzymatic activity of the neuraminidase enzyme.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2014001768A MX352708B (en) | 2014-02-13 | 2014-02-13 | Use of n-acetylphenylalanylmethionine and chemical derivatives thereof as inhibitors of the neuraminidase of human and animal influenza virus. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2014001768A MX352708B (en) | 2014-02-13 | 2014-02-13 | Use of n-acetylphenylalanylmethionine and chemical derivatives thereof as inhibitors of the neuraminidase of human and animal influenza virus. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2014001768A MX2014001768A (en) | 2015-08-13 |
| MX352708B true MX352708B (en) | 2017-10-24 |
Family
ID=54598904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014001768A MX352708B (en) | 2014-02-13 | 2014-02-13 | Use of n-acetylphenylalanylmethionine and chemical derivatives thereof as inhibitors of the neuraminidase of human and animal influenza virus. |
Country Status (1)
| Country | Link |
|---|---|
| MX (1) | MX352708B (en) |
-
2014
- 2014-02-13 MX MX2014001768A patent/MX352708B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| MX2014001768A (en) | 2015-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112016018555A8 (en) | CYCLOPROPYLAMINES AS LSD1 INHIBITORS, THEIR USE, PHARMACEUTICAL COMPOSITION INCLUDING THEM AND LSD1 INHIBITION METHOD | |
| BR112016024414A2 (en) | irak inhibitors and uses thereof | |
| BR112015021999A2 (en) | 2,3-dioxigenase indoleamine inhibitors (acid) | |
| EA201590457A1 (en) | SULFAMOIL-Arylamides and Their Use as Medicinal Products for the Treatment of Hepatitis B | |
| EA201691481A1 (en) | C5a inhibitors for the treatment of viral pneumonia | |
| BR112019000589A2 (en) | pyrimidine carboxamides as inhibitors of vanin-1 enzyme | |
| PH12017501095A1 (en) | Piperidine derivatives as hdac1/2 inhibitors | |
| PH12016501462A1 (en) | Neprilysin inhibitors | |
| EA201590703A1 (en) | MEK INHIBITORS FOR TREATING VIRAL DISEASES | |
| UA116999C2 (en) | SELECTED HEMAGLUTIN ANTIBODY AND PHARMACEUTICAL COMPOSITION TO BE CONTAINED | |
| EA201692313A1 (en) | Derivatives of indolysine as inhibitors of phosphosinositide-3-kinase | |
| EA201792057A1 (en) | CONDENSED BICYCLIC HETEROYARIL DERIVATIVES WITH ACTIVITY OF PROHYLDROXYLASE INHIBITORS | |
| BR112017001334A2 (en) | imidazopyridazine compounds, their use and pharmaceutical composition comprising them | |
| PH12016501461A1 (en) | 5-biphenyl-4-heteroarylcarbonylamino-pentanoic acid derivatives as neprilysin inhibitors | |
| NZ710291A (en) | 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions | |
| MX2016000480A (en) | High potency pancreatin pharmaceutical compositions. | |
| MX2019006863A (en) | Heparanase inhibitors and use thereof. | |
| IL269900B (en) | Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication | |
| PH12017500595B1 (en) | Aldosterone synthase inhibitors | |
| MX2018005872A (en) | Nucleic acid prodrugs. | |
| MX373272B (en) | Combination therapy | |
| MX2017002768A (en) | Antiviral agents and uses thereof. | |
| MX364704B (en) | Inhibitors of viral replication, their process of preparation and their therapeutical uses. | |
| MX2015010763A (en) | H5 proteins of h5n1 influenza virus for use as a medicament. | |
| MX352708B (en) | Use of n-acetylphenylalanylmethionine and chemical derivatives thereof as inhibitors of the neuraminidase of human and animal influenza virus. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |